TrialEuropean journal of nuclear medicine and molecular imaging2006

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

J P Esser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.